| 000 | 01170 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517013539.0 | ||
| 264 | 0 | _c20150518 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1600-0404 | ||
| 024 | 7 |
_a10.1111/ane.12357 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSignoriello, E | |
| 245 | 0 | 0 |
_aFingolimod efficacy in multiple sclerosis associated with Sjogren syndrome. _h[electronic resource] |
| 260 |
_bActa neurologica Scandinavica _cFeb 2015 |
||
| 300 |
_a140-3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFingolimod Hydrochloride |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xcomplications |
| 650 | 0 | 4 |
_aPropylene Glycols _xtherapeutic use |
| 650 | 0 | 4 |
_aSjogren's Syndrome _xcomplications |
| 650 | 0 | 4 |
_aSphingosine _xanalogs & derivatives |
| 700 | 1 | _aSagliocchi, A | |
| 700 | 1 | _aFratta, M | |
| 700 | 1 | _aLus, G | |
| 773 | 0 |
_tActa neurologica Scandinavica _gvol. 131 _gno. 2 _gp. 140-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ane.12357 _zAvailable from publisher's website |
| 999 |
_c24566698 _d24566698 |
||